Automated Antimicrobial Susceptibility Testing Market

Automated antimicrobial susceptibility testing is extensively used to achieve minimum inhibitory concentration (MIC) results using an antimicrobial susceptibility testing system, which offers flexible, customizable testing options to accommodate laboratories of all sizes. Antimicrobial susceptibility testing (AST) aims to ensure that suitable antibiotics are prescribed to individuals by monitoring inhibition zone of antibiotics and emergence of resistant pathogens in infected individuals. Information on local patterns of antimicrobial susceptibility can be collected using antimicrobial susceptibility testing, so that policies guiding the therapy can be based on current data on local resistance trends or institutional antibiogram.
Automated Antimicrobial Susceptibility Testing Market contains market size and forecasts of Automated Antimicrobial Susceptibility Testing in Global, including the following market information:
Global Automated Antimicrobial Susceptibility Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Automated Antimicrobial Susceptibility Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Consumables Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Automated Antimicrobial Susceptibility Testing include bioM?rieux, HiMedia Laboratories, Alifax Holding, Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific and Merck KGaA and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Automated Antimicrobial Susceptibility Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Automated Antimicrobial Susceptibility Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Automated Antimicrobial Susceptibility Testing Market Segment Percentages, by Type, 2021 (%)
Consumables
Instruments
Global Automated Antimicrobial Susceptibility Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Automated Antimicrobial Susceptibility Testing Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Hospitals
Pathology or Diagnostic Laboratories
Global Automated Antimicrobial Susceptibility Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Automated Antimicrobial Susceptibility Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Automated Antimicrobial Susceptibility Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Automated Antimicrobial Susceptibility Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
bioM?rieux
HiMedia Laboratories
Alifax Holding
Creative Diagnostics
Resistell AG
Danaher Corporation
Becton, Dickinson and Company
Thermo Fisher Scientific
Merck KGaA
Bio-Rad Laboratories